Ning Xie1, Dehua Liao2, Binliang Liu1

  • 1Department of Breast Cancer Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.

概括

研究人员确定了两个关键代谢物FAPy-adenine和2-pyrocatechuic acid,作为预测治疗反应的潜在生物标志物,在接受inetetamab治疗的HER2-阳性乳腺癌 (BC) 患者中.